Related Experiment Video

Updated: Dec 1, 2025

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

9.0K

Loss of Aurora Kinase Signaling Allows Lung Cancer Cells to Adopt Endoreplication and Form Polyploid Giant Cancer

Vural Tagal1, Michael G Roth2,3

  • 1Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas. vural.tagal@utsouthwestern.edu.

Cancer Research
|November 11, 2020
PubMed

Insights

Aurora kinases drive polyploid giant cancer cell (PGCC) formation in lung cancer. Inhibiting these kinases causes PGCCs, potentially leading to therapy resistance and tumor relapse.

Area of Science:

  • Oncology
  • Cell Biology
  • Cancer Research

Background:

  • Polyploid giant cancer cells (PGCCs) are prevalent in tumors and linked to poor prognosis.
  • Mechanisms driving PGCC formation remain largely unknown.
  • PGCCs are associated with therapy resistance, metastasis, and tumor relapse.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying Polyploid giant cancer cell (PGCC) formation.
  • To identify the role of Aurora kinases in the transition to polyploidy and multinucleation.
  • To explore the implications of PGCC formation in response to Aurora kinase inhibitors.

Main Methods:

  • Utilized lung cancer cell lines to study cell cycle dynamics.
  • Investigated the effects of combined Aurora kinase inhibition.
  • Analyzed cell morphology, ploidy, and cell cycle progression under antimitotic stress.

Main Results:

  • Simultaneous inhibition of Aurora kinases induced uniform formation of multinucleated PGCCs in lung cancer cells.
  • These PGCCs underwent endoreplication, bypassing mitosis and increasing cell size.
  • PGCCs survived antimitotic treatment and re-entered the cell cycle upon drug removal, increasing cell numbers.

Conclusions:

  • Aurora kinases are critical regulators of the switch to polyploid growth and multinucleation.
  • PGCC formation represents a cellular response to Aurora kinase inhibition, contributing to therapeutic resistance.
  • These findings offer insights into mechanisms of resistance against Aurora kinase inhibitors and antimitotic drugs.

More Related Videos

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on: June 26, 2019

8.2K
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.3K

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.4K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.5K